Xiaoli Tang

1.7k citations
60 papers · 1.3k indexed · h-index 19
Topics
MicroRNA in disease regulation (14 papers)Cancer-related molecular mechanisms research (10 papers)RNA Research and Splicing (7 papers)
Partner nations
ChinaUnited StatesIndia

In The Last Decade

Xiaoli Tang

57 papers receiving 1.3k citations

Peers

Xiaoli Tang
Comparison fields: 5 of 106
  • Molecular Biology 850
  • Cancer Research 473
  • Oncology 223
  • Surgery 141
  • Genetics 117
Replace Julie Mathieu with:
Julie Mathieu United States
Hao Ding Canada
Éric Lacazette France
Eileen Southon United States
Roberta Melchionna Italy
Duanduan Ma United States
Pilar Gonzalo Spain
Jifang Wen China
Xiaoli Tang relative to Julie Mathieu United States Julie Mathieu's profile →
Citations per field
00.5×1.5×2.0×
Julie Mathieu · 1×
Citations per year

Countries citing papers authored by Xiaoli Tang

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Tang more than expected).

Fields of papers citing papers by Xiaoli Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Tang. The network helps show where Xiaoli Tang may publish in the future.

Co-authorship network of co-authors of Xiaoli Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Tang. A scholar is included among the top collaborators of Xiaoli Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Tang. Xiaoli Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 15
4 2
5 1
6 0
7 4
8 4
9 1
10 3
11 13
12 22
13 19
14 18
15 106
16 11
17 66
18 87
19 6
20
Effects of astragalus root on the expression of P16 mRNA and telomere of human dermal fibroblasts by serum pharmacology
0

About Xiaoli Tang

Xiaoli Tang is a scholar working on Cancer Research, Immunology and Molecular Biology, having authored 60 papers that have together received 1.3k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (14 papers), Cancer-related molecular mechanisms research (10 papers) and RNA Research and Splicing (7 papers). The work is most often cited by research in Cancer Research (473 citations), Molecular Biology (850 citations) and Oncology (223 citations). Xiaoli Tang has collaborated with scholars based in China, United States and India. Frequent co-authors include Bharat Ramratnam, Lynne Tucker, Zheng Dong, Yingjie Zhang, Junmin Peng, Xiaoming Gong, Wang Xuemin, Leslie A.C. Blair, John Marshall and Marcus Wiedmann. Their work appears in journals such as Nucleic Acids Research, Neuron and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026